Cladribine nucleotide pools are diminished in resistant myeloma cell fines, as compared to sensitive lymphoma cell lines.

被引:0
|
作者
Hoffman, MA [1 ]
Xu, JC [1 ]
Rai, KR [1 ]
机构
[1] LONG ISL JEWISH MED CTR,NEW HYDE PK,NY 11042
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3640 / 3640
页数:1
相关论文
共 50 条
  • [21] Rapamycin enhances the cytotoxicity of bortezomib and rituximab on mantle cell lymphoma (MCL) cell lines.
    Ismail, LK
    Timm, M
    Novak, A
    Stenson, M
    Ansell, SM
    Witzig, TE
    BLOOD, 2005, 106 (11) : 678A - 678A
  • [22] The induction of apoptosis by interferon-alpha on myeloma and CML cell lines.
    Suzuki, S
    Takagi, S
    Miyata, M
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 319 - 319
  • [23] DEVELOPMENT AND CHARACTERIZATION OF BORTEZOMIB RESISTANT MYELOMA CELL LINES
    Schoester, M.
    Van Duin, M.
    De Knegt, Y.
    Corthals, S. L.
    Broyl, A.
    Sonneveld, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 313 - 314
  • [24] Comparative effects of fludarabine, cladribine and pentostatin on nucleoside metabolism in human T-cell and B-cell lines.
    Wilson, PK
    Szabados, E
    Henderson, DS
    Mulligan, SP
    Christopherson, RI
    BLOOD, 1997, 90 (10) : 4149 - 4149
  • [25] Suppressor p53 in B-cell lymphoma lines.
    Wu, YL
    Heckman, CA
    Boxer, LM
    BLOOD, 1999, 94 (10) : 58A - 58A
  • [26] Analysis of Epstein-Barr virus infections in lymphoma cell lines.
    Uphoff, CC
    Denkmann, SA
    Drexler, HG
    BLOOD, 2005, 106 (11) : 57B - 57B
  • [27] Detection of human pathogenic viruses in human leukemia and lymphoma cell lines.
    Uphoff, CC
    Drexler, HG
    BLOOD, 2001, 98 (11) : 207B - 208B
  • [28] Synergistic anticancer effects between curcumin and doxorubicin in drug sensitive and resistant human pediatric leukemic cell lines.
    Ramachandran, Cheppail
    Nair, P. K. Raveendran
    Escalon, Enrique
    Melnick, Steven J.
    Khatib, Ziad
    BLOOD, 2006, 108 (11) : 168B - 168B
  • [29] Expression of T-cell associated transcription factors in Hodgkin lymphoma tissues and cell lines.
    Atayar, C
    Blokzijl, T
    Boot, M
    van den Berg, A
    Poppema, S
    BLOOD, 2003, 102 (11) : 892A - 892A
  • [30] Differential sensitivity to fas mediated apoptosis in drug resistant cell lines.
    Landowski, TH
    Guzman, MG
    Dalton, WS
    BLOOD, 1996, 88 (10) : 253 - 253